{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T09:38:23Z","timestamp":1769161103378,"version":"3.49.0"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jsbmb.2019.01.017","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T04:40:09Z","timestamp":1548736809000},"page":"263-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["In silico and functional studies reveal novel loss-of-function variants of SRD5A2, but no variants explaining excess 5\u03b1-reductase activity"],"prefix":"10.1016","volume":"190","author":[{"given":"Efstathios","family":"Katharopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kay","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8331-5902","authenticated-orcid":false,"given":"Amit V.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa E.","family":"Fl\u00fcck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2019.01.017_bib0005","series-title":"Endocrinology of the Testis and Male Reproduction","first-page":"343","author":"Fl\u00fcck","year":"2017"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0010","first-page":"577","article-title":"Steroid 5 alpha-reductase 2 deficiency","volume":"14","author":"Wilson","year":"1993","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0020","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0039-128X(80)90074-4","article-title":"Substrate specificity of the placental microsomal aromatase","volume":"36","author":"Gibb","year":"1980","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0025","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.biocel.2009.11.013","article-title":"Molecular cell biology of androgen receptor signalling","volume":"42","author":"Bennett","year":"2010","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0030","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mce.2014.12.009","article-title":"11beta-Hydroxyandrostenedione: downstream metabolism by 11betaHSD, 17betaHSD and SRD5A produces novel substrates in familiar pathways","volume":"408","author":"Swart","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0035","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1210\/jc.2003-030143","article-title":"The 17, 20-Lyase activity of cytochrome P450c17 from human fetal testis favors the \u03945 steroidogenic pathway","volume":"88","author":"Fl\u00fcck","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0040","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/en.2002-220721","article-title":"5\u03b1-androstane-3\u03b1,17\u03b2-diol is formed in tammar wallaby pouch young testes by a pathway involving 5\u03b1-pregnane-3\u03b1,17\u03b1-diol-20-one as a key intermediate","volume":"144","author":"Wilson","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0045","doi-asserted-by":"crossref","first-page":"12256","DOI":"10.1073\/pnas.220412297","article-title":"Prostate formation in a marsupial is mediated by the testicular androgen 5 alpha-androstane-3 alpha,17 beta-diol","volume":"97","author":"Shaw","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ajhg.2011.06.009","article-title":"Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation","volume":"89","author":"Fluck","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.mce.2013.01.017","article-title":"Of marsupials and men: \u201cBackdoor\u201d dihydrotestosterone synthesis in male sexual differentiation","volume":"371","author":"Biason-Lauber","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mce.2013.07.006","article-title":"11beta-Hydroxydihydrotestosterone and 11-ketodihydrotestosterone, novel C19 steroids with androgenic activity: a putative role in castration resistant prostate cancer?","volume":"377","author":"Storbeck","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0065","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jsbmb.2016.07.009","article-title":"Androgen biosynthesis during minipuberty favors the backdoor pathway over the classic pathway: Insights into enzyme activities and steroid fluxes in healthy infants during the first year of life from the urinary steroid metabolome","volume":"165","author":"Dhayat","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0070","doi-asserted-by":"crossref","first-page":"13228","DOI":"10.3390\/molecules181113228","article-title":"11beta-hydroxyandrostenedione returns to the steroid arena: biosynthesis, metabolism and function","volume":"18","author":"Bloem","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0024-3205(02)01627-2","article-title":"Comparative study of human steroid 5alpha-reductase isoforms in prostate and female breast skin tissues: sensitivity to inhibition by finasteride and epristeride","volume":"71","author":"Ranjan","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0080","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1073\/pnas.87.10.3640","article-title":"Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases","volume":"87","author":"Andersson","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0085","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1172\/JCI116665","article-title":"Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression","volume":"92","author":"Thigpen","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0090","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1515\/HMBCI.2010.035","article-title":"Human type 3 5alpha-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride","volume":"2","author":"Yamana","year":"2010","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0095","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cell.2010.07.003","article-title":"SRD5A3: A surprising role in glycosylation","volume":"142","author":"Stiles","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0100","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1074\/jbc.M211684200","article-title":"Identification of two mammalian reductases involved in the two-carbon fatty acyl elongation cascade","volume":"278","author":"Moon","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0105","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1210\/endo.131.3.1505484","article-title":"Structure of human type II 5 alpha-reductase gene","volume":"131","author":"Labrie","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0110","first-page":"958","article-title":"Localization of the reduced nicotinamide adenine dinucleotide phosphate: \u03944-3-ketosteroid 5\u03b1-oxidoreductase in the nuclear membrane of the rat ventral","volume":"247","author":"J","year":"1972","journal-title":"Prostate JBC"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0115","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0960-0760(94)00183-M","article-title":"Cloning, expression and functional characterization of type 1 and type 2 steroid 5 alpha-reductases from Cynomolgus monkey: comparisons with human and rat isoenzymes","volume":"52","author":"Levy","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev.bi.63.070194.000325","article-title":"Steroid 5 alpha-reductase: two genes\/two enzymes","volume":"63","author":"Russell","year":"1994","journal-title":"Ann. Rev. Biochem."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/354159a0","article-title":"Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism","volume":"354","author":"Andersson","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0130","doi-asserted-by":"crossref","first-page":"19548","DOI":"10.1016\/S0021-9258(18)41809-1","article-title":"Tissue distribution and kinetic characteristics of rat steroid 5 alpha-reductase isozymes. Evidence for distinct physiological functions","volume":"267","author":"Normington","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1349-7006.2007.00656.x","article-title":"Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer","volume":"99","author":"Uemura","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0140","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1210\/jc.2002-021415","article-title":"Micropenis and the 5alpha-reductase-2 (SRD5A2) gene: mutation and V89L polymorphism analysis in 81 Japanese patients","volume":"88","author":"Sasaki","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0145","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1210\/jc.2010-1024","article-title":"Phenotypical, biological, and molecular heterogeneity of 5alpha-reductase deficiency: an extensive international experience of 55 patients","volume":"96","author":"Maimoun","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0150","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jsbmb.2016.05.020","article-title":"Steroid 5alpha-reductase 2 deficiency","volume":"163","author":"Mendonca","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0155","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1055\/s-0036-1585403","article-title":"Genome-wide association studies for polycystic ovary syndrome","volume":"34","author":"Liu","year":"2016","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0160","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1158\/1055-9965.EPI-16-1046","article-title":"A review of prostate cancer genome-wide association studies (GWAS)","volume":"27","author":"Benafif","year":"2018","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0165","first-page":"2414","article-title":"5alpha-reductase activity in women with polycystic ovary syndrome","volume":"84","author":"Jakimiuk","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0170","article-title":"Genes and proteins of the alternative steroid backdoor pathway for dihydrotestosterone synthesis are expressed in the human ovary and seem enhanced in the polycystic ovary syndrome","volume":"25","author":"Marti","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0175","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mce.2017.05.014","article-title":"Androgen production in pediatric adrenocortical tumors may occur via both the classic and\/or the alternative backdoor pathway","volume":"452","author":"Marti","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0180","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.eururo.2007.10.052","article-title":"Type 1 and type 2 5alpha-reductase expression in the development and progression of prostate cancer","volume":"53","author":"Thomas","year":"2008","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0185","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/pros.20188","article-title":"Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer","volume":"63","author":"Thomas","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0190","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0960-0760(99)00030-8","article-title":"Differences in steroid 5\u03b1-reductase iso-enzymes expression between normal and pathological human prostate tissue","volume":"68","author":"Iehl\u00e9","year":"1999","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0195","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1097-0045(199610)29:4<261::AID-PROS7>3.0.CO;2-E","article-title":"Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas","volume":"29","author":"Bonkhoff","year":"1996","journal-title":"Prostate"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0200","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1210\/jc.2003-030240","article-title":"Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates","volume":"88","author":"Tsilchorozidou","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0205","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1210\/jc.2002-021875","article-title":"Beyond adrenal and ovarian androgen generation: increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome","volume":"88","author":"Fassnacht","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/JPEM.2000.13.3.253","article-title":"Increased 5alpha-reductase and normal 11beta-hydroxysteroid dehydrogenase metabolism of C19 and C21 steroids in a young population with polycystic ovarian syndrome","volume":"13","author":"Chin","year":"2000","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0215","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0015-0282(16)55316-3","article-title":"Cutaneous application of an androstenedione gel as an in vivo test of 5 alpha-reductase activity in women","volume":"58","author":"Miles","year":"1992","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0220","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12958-017-0242-9","article-title":"5alpha-reductase activity in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"15","author":"Wu","year":"2017","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0225","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0140-6736(90)90664-Q","article-title":"5 alpha-reductase activity in polycystic ovary syndrome","volume":"335","author":"Stewart","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0230","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1210\/jc.2015-3926","article-title":"Evidence for increased 5alpha-reductase activity during early childhood in daughters of women with polycystic ovary syndrome","volume":"101","author":"Torchen","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0235","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0240","first-page":"3415","article-title":"Nonisotopic single strand conformation analysis of the 5 alpha-reductase type 2 gene for the diagnosis of 5 alpha-reductase deficiency","volume":"81","author":"Hiort","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0245","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(98)11282-5","article-title":"Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA","volume":"354","author":"Makridakis","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0250","doi-asserted-by":"crossref","first-page":"W344","DOI":"10.1093\/nar\/gkw408","article-title":"ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules","volume":"44","author":"Ashkenazy","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0255","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature13797","article-title":"Structure of an integral membrane sterol reductase from Methylomicrobium alcaliphilum","volume":"517","author":"Li","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0260","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/prot.20251","article-title":"Making optimal use of empirical energy functions: force-field parameterization in crystal space","volume":"57","author":"Krieger","year":"2004","journal-title":"Proteins"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0265","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0263-7855(90)80070-V","article-title":"WHAT IF: a molecular modeling and drug design program","volume":"8","author":"Vriend","year":"1990","journal-title":"J. Mol. Graphics"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0270","series-title":"AMBER 2017","author":"Case","year":"2017"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0275","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1126\/science.1853201","article-title":"A method to identify protein sequences that fold into a known three-dimensional structure","volume":"253","author":"Bowie","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0280","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/356083a0","article-title":"Assessment of protein models with three-dimensional profiles","volume":"356","author":"Luthy","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0285","first-page":"425","article-title":"Objectively judging the quality of a protein structure from a Ramachandran plot","volume":"13","author":"Hooft","year":"1997","journal-title":"Comput. Appl. Biosci."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0290","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-2836(63)80023-6","article-title":"Stereochemistry of polypeptide chain configurations","volume":"7","author":"Ramachandran","year":"1963","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0295","unstructured":"L. Schr\u00f6dinger, The PyMOL Molecular Graphics System, Version 2.0."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0300","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0305","doi-asserted-by":"crossref","first-page":"W229","DOI":"10.1093\/nar\/gkx439","article-title":"SDM: a server for predicting effects of mutations on protein stability","volume":"45","author":"Pandurangan","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0310","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/cen.12293","article-title":"STAR splicing mutations cause the severe phenotype of lipoid congenital adrenal hyperplasia: insights from a novel splice mutation and review of reported cases","volume":"80","author":"Camats","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068691","article-title":"Differential regulation of human 3beta-hydroxysteroid dehydrogenase type 2 for steroid hormone biosynthesis by starvation and cyclic AMP stimulation: studies in the human adrenal NCI-H295R cell model","volume":"8","author":"Udhane","year":"2013","journal-title":"PLoS One"},{"issue":"532\u2013534","key":"10.1016\/j.jsbmb.2019.01.017_bib0320","first-page":"536","article-title":"A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples","volume":"15","author":"Chomczynski","year":"1993","journal-title":"Biotechniques"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0325","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0042-6822(73)90341-3","article-title":"A new technique for the assay of infectivity of human adenovirus 5 DNA","volume":"52","author":"Graham","year":"1973","journal-title":"Virology"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0330","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0092-8674(77)90333-6","article-title":"Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells","volume":"11","author":"Wigler","year":"1977","journal-title":"Cell"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0335","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1074\/jbc.273.6.3158","article-title":"Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer","volume":"273","author":"Auchus","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0340","doi-asserted-by":"crossref","DOI":"10.1038\/srep10132","article-title":"Retinoic acid receptor beta and angiopoietin-like protein 1 are involved in the regulation of human androgen biosynthesis","volume":"5","author":"Udhane","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0345","doi-asserted-by":"crossref","first-page":"16249","DOI":"10.1016\/S0021-9258(18)71614-1","article-title":"Expression cloning and regulation of steroid 5 alpha-reductase, an enzyme essential for male sexual differentiation","volume":"264","author":"Andersson","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0350","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0014-5793(85)80912-1","article-title":"Evidence that human prostatic 5 alpha-reductase is located exclusively in the nucleus","volume":"185","author":"Houston","year":"1985","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0355","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0303-7207(95)03526-D","article-title":"5\u03b1-Reductase type 1 is localized to the outer nuclear membrane","volume":"110","author":"Savory","year":"1995","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0360","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000445090","article-title":"5alpha-reductase-2 deficiency: clinical findings, endocrine pitfalls, and genetic features in a large Italian cohort","volume":"10","author":"Bertelloni","year":"2016","journal-title":"Sex. Dev."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0365","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1365-2265.2003.01763.x","article-title":"Molecular analysis of 5alpha-reductase type 2 gene in eight unrelated egyptian children with suspected 5alpha-reductase deficiency: prevalence of the G34R mutation","volume":"58","author":"Mazen","year":"2003","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0370","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1021\/bi00171a029","article-title":"Natural mutagenesis study of the human steroid 5 alpha-reductase 2 isozyme","volume":"33","author":"Wigley","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0375","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1172\/JCI115954","article-title":"Molecular genetics of steroid 5 alpha-reductase 2 deficiency","volume":"90","author":"Thigpen","year":"1992","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0380","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/hmg\/ddn145","article-title":"No association between the SRD5A2 gene A49T missense variant and prostate cancer risk: lessons learned","volume":"17","author":"Pearce","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0385","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.eururo.2005.06.011","article-title":"The 5alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population","volume":"48","author":"Giwercman","year":"2005","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0390","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ijc.22408","article-title":"5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia","volume":"120","author":"Hayes","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0395","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1054\/bjoc.2001.1789","article-title":"A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland","volume":"84","author":"Mononen","year":"2001","journal-title":"Br. J Cancer"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0400","first-page":"1077","article-title":"Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study","volume":"10","author":"Hsing","year":"2001","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0405","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1590\/S0100-879X2002000200009","article-title":"Allelic frequencies of six polymorphic markers for risk of prostate cancer","volume":"35","author":"Ribeiro","year":"2002","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0410","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2164\/jandrol.107.002592","article-title":"Molecular characterization of 6 unrelated Italian patients with 5alpha-reductase type 2 deficiency","volume":"29","author":"Baldinotti","year":"2008","journal-title":"J. Androl."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0415","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0022-5347(01)68102-3","article-title":"5alpha-reductase type 2 mutations are present in some boys with isolated hypospadias","volume":"162","author":"Silver","year":"1999","journal-title":"J. Urol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0420","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s40618-016-0573-y","article-title":"Association of SRD5A2 gene mutations with risk of hypospadias in the Iranian population","volume":"40","author":"Rahimi","year":"2017","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0425","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.biopen.2017.03.003","article-title":"Subcellular localization of the five members of the human steroid 5alpha-reductase family","volume":"4","author":"Scaglione","year":"2017","journal-title":"Biochim. Open"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0430","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.1038\/sj.onc.1207922","article-title":"Identification and characterization of somatic steroid 5alpha-reductase (SRD5A2) mutations in human prostate cancer tissue","volume":"23","author":"Makridakis","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0435","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1021\/bi00072a028","article-title":"Finasteride: a slow-binding 5 alpha-reductase inhibitor","volume":"32","author":"Faller","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0440","series-title":"In silico structural prediction of human steroid 5\u03b1-reductase type II","author":"Karnsomwan","year":"2016"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0445","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ajpath.2014.11.020","article-title":"DNA methyl transferase 1 reduces expression of SRD5A2 in the aging adult prostate","volume":"185","author":"Ge","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0450","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.juro.2015.04.079","article-title":"Age and obesity promote methylation and suppression of 5alpha-reductase 2: implications for personalized therapy of benign prostatic hyperplasia","volume":"194","author":"Bechis","year":"2015","journal-title":"J. Urol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0455","first-page":"018","article-title":"Correlation between 5-alpha reductase type 2 protein expression and methylation of 5-alpha reductase type 2 promotor gene of benign prostatic hyperplasia","volume":"1","author":"Kang","year":"2018","journal-title":"World J. Urol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0460","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/pros.23195","article-title":"NF-kappaB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance","volume":"76","author":"Austin","year":"2016","journal-title":"Prostate"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0465","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1210\/en.2016-1926","article-title":"Inverse regulation of DHT synthesis enzymes 5\u03b1-reductase types 1 and 2 by the androgen receptor in prostate cancer","volume":"158","author":"Audet-Walsh","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0470","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1016\/j.yexcr.2009.05.025","article-title":"Regulation of steroid 5-alpha reductase type 2 (Srd5a2) by sterol regulatory element binding proteins and statin","volume":"315","author":"Seo","year":"2009","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0475","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3389\/fphar.2018.00773","article-title":"Berberine improves benign prostatic hyperplasia via suppression of 5 alpha reductase and extracellular signal-regulated kinase in vivo and in vitro","volume":"9","author":"Youn","year":"2018","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0480","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1210\/jc.2006-0227","article-title":"Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women","volume":"91","author":"Goodarzi","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0485","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1158\/1078-0432.CCR-13-1100","article-title":"Importance of 5 alpha-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer","volume":"20","author":"Levesque","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jsbmb.2019.01.017_bib0490","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr Rev."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076018305880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076018305880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:03:48Z","timestamp":1760745828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076018305880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":98,"alternative-id":["S0960076018305880"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2019.01.017","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico and functional studies reveal novel loss-of-function variants of SRD5A2, but no variants explaining excess 5\u03b1-reductase activity","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2019.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}